GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (FRA:7CA) » Definitions » 5-Year EBITDA Growth Rate

Camurus AB (FRA:7CA) 5-Year EBITDA Growth Rate : 0.00% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Camurus AB 5-Year EBITDA Growth Rate?

Camurus AB's EBITDA per Share for the three months ended in Mar. 2024 was €0.15.

During the past 12 months, Camurus AB's average EBITDA Per Share Growth Rate was 264.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Camurus AB was 36.30% per year. The lowest was -44.10% per year. And the median was 2.00% per year.


Competitive Comparison of Camurus AB's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, Camurus AB's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camurus AB's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Camurus AB's 5-Year EBITDA Growth Rate falls into.



Camurus AB 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Camurus AB  (FRA:7CA) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Camurus AB 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Camurus AB's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Camurus AB (FRA:7CA) Business Description

Industry
Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032, and others. The company's geographical revenue includes Europe (of which Sweden), the United States of America, Australia, and Other geographical areas.

Camurus AB (FRA:7CA) Headlines

No Headlines